Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective

OBJECTIVES: To evaluate the cost effectiveness of onabotulinumtoxinA (BOTOX(®), 200 units [200 U]) for the management of urinary incontinence (UI) in adults with neurogenic detrusor overactivity (NDO) due to subcervical spinal cord injury or multiple sclerosis that is not adequately managed with ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamid, Rizwan, Loveman, Clara, Millen, Jim, Globe, Denise, Corbell, Catherine, Colayco, Danielle, Stanisic, Sanja, Gultyaev, Dmitry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381108/
https://www.ncbi.nlm.nih.gov/pubmed/25526842
http://dx.doi.org/10.1007/s40273-014-0245-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381108/
https://www.ncbi.nlm.nih.gov/pubmed/25526842
http://dx.doi.org/10.1007/s40273-014-0245-8

Ejemplares similares